Industry: Medical Devices & Consumables
Published Date: 2025-01-01
Pages: 112 Pages
Report ld: 3452337
Request Sample
Customized Report
The global market for Artificial Dermis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Artificial Dermis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Artificial Dermis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Artificial Dermis include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, Gunze, Tissue Regenix, Zimmer Biomet, Integra LifeSciences, Organogenesis, Flower Orthopedics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Artificial Dermis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Dermis.
The Artificial Dermis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Dermis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Dermis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
Segment by Type
From Animal Source
From Human Source
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Dermis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Dermis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Artificial Dermis Market Overview
1.1 Product Definition
1.2 Artificial Dermis by Type
1.2.1 Global Artificial Dermis Market Value Comparison by Type (2024 VS 2031)
1.2.2 From Animal Source
1.2.3 From Human Source
1.3 Artificial Dermis by Application
1.3.1 Global Artificial Dermis Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Dermis Market Size Estimates and Forecasts
1.4.1 Global Artificial Dermis Revenue 2020-2031
1.4.2 Global Artificial Dermis Sales 2020-2031
1.4.3 Global Artificial Dermis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Artificial Dermis Market Competition by Manufacturers
2.1 Global Artificial Dermis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Artificial Dermis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Artificial Dermis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Artificial Dermis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Dermis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Dermis, Product Type & Application
2.7 Global Key Manufacturers of Artificial Dermis, Date of Enter into This Industry
2.8 Global Artificial Dermis Market Competitive Situation and Trends
2.8.1 Global Artificial Dermis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Artificial Dermis Players Market Share by Revenue
2.8.3 Global Artificial Dermis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Dermis Market Scenario by Region
3.1 Global Artificial Dermis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Artificial Dermis Sales by Region: 2020-2031
3.2.1 Global Artificial Dermis Sales by Region: 2020-2025
3.2.2 Global Artificial Dermis Sales by Region: 2026-2031
3.3 Global Artificial Dermis Revenue by Region: 2020-2031
3.3.1 Global Artificial Dermis Revenue by Region: 2020-2025
3.3.2 Global Artificial Dermis Revenue by Region: 2026-2031
3.4 North America Artificial Dermis Market Facts & Figures by Country
3.4.1 North America Artificial Dermis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Artificial Dermis Sales by Country (2020-2031)
3.4.3 North America Artificial Dermis Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Dermis Market Facts & Figures by Country
3.5.1 Europe Artificial Dermis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Artificial Dermis Sales by Country (2020-2031)
3.5.3 Europe Artificial Dermis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Dermis Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Dermis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Artificial Dermis Sales by Region (2020-2031)
3.6.3 Asia Pacific Artificial Dermis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Dermis Market Facts & Figures by Country
3.7.1 Latin America Artificial Dermis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Artificial Dermis Sales by Country (2020-2031)
3.7.3 Latin America Artificial Dermis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Dermis Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Dermis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Artificial Dermis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Artificial Dermis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Dermis Sales by Type (2020-2031)
4.1.1 Global Artificial Dermis Sales by Type (2020-2025)
4.1.2 Global Artificial Dermis Sales by Type (2026-2031)
4.1.3 Global Artificial Dermis Sales Market Share by Type (2020-2031)
4.2 Global Artificial Dermis Revenue by Type (2020-2031)
4.2.1 Global Artificial Dermis Revenue by Type (2020-2025)
4.2.2 Global Artificial Dermis Revenue by Type (2026-2031)
4.2.3 Global Artificial Dermis Revenue Market Share by Type (2020-2031)
4.3 Global Artificial Dermis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Artificial Dermis Sales by Application (2020-2031)
5.1.1 Global Artificial Dermis Sales by Application (2020-2025)
5.1.2 Global Artificial Dermis Sales by Application (2026-2031)
5.1.3 Global Artificial Dermis Sales Market Share by Application (2020-2031)
5.2 Global Artificial Dermis Revenue by Application (2020-2031)
5.2.1 Global Artificial Dermis Revenue by Application (2020-2025)
5.2.2 Global Artificial Dermis Revenue by Application (2026-2031)
5.2.3 Global Artificial Dermis Revenue Market Share by Application (2020-2031)
5.3 Global Artificial Dermis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MTF Biologics
6.1.1 MTF Biologics Company Information
6.1.2 MTF Biologics Description and Business Overview
6.1.3 MTF Biologics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MTF Biologics Artificial Dermis Product Portfolio
6.1.5 MTF Biologics Recent Developments/Updates
6.2 Allosource
6.2.1 Allosource Company Information
6.2.2 Allosource Description and Business Overview
6.2.3 Allosource Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allosource Artificial Dermis Product Portfolio
6.2.5 Allosource Recent Developments/Updates
6.3 Parametrics Medical
6.3.1 Parametrics Medical Company Information
6.3.2 Parametrics Medical Description and Business Overview
6.3.3 Parametrics Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Parametrics Medical Artificial Dermis Product Portfolio
6.3.5 Parametrics Medical Recent Developments/Updates
6.4 LifeNet Health
6.4.1 LifeNet Health Company Information
6.4.2 LifeNet Health Description and Business Overview
6.4.3 LifeNet Health Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LifeNet Health Artificial Dermis Product Portfolio
6.4.5 LifeNet Health Recent Developments/Updates
6.5 Gunze
6.5.1 Gunze Company Information
6.5.2 Gunze Description and Business Overview
6.5.3 Gunze Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Gunze Artificial Dermis Product Portfolio
6.5.5 Gunze Recent Developments/Updates
6.6 Tissue Regenix
6.6.1 Tissue Regenix Company Information
6.6.2 Tissue Regenix Description and Business Overview
6.6.3 Tissue Regenix Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tissue Regenix Artificial Dermis Product Portfolio
6.6.5 Tissue Regenix Recent Developments/Updates
6.7 Zimmer Biomet
6.7.1 Zimmer Biomet Company Information
6.7.2 Zimmer Biomet Description and Business Overview
6.7.3 Zimmer Biomet Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zimmer Biomet Artificial Dermis Product Portfolio
6.7.5 Zimmer Biomet Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Company Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Integra LifeSciences Artificial Dermis Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 Organogenesis
6.9.1 Organogenesis Company Information
6.9.2 Organogenesis Description and Business Overview
6.9.3 Organogenesis Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Organogenesis Artificial Dermis Product Portfolio
6.9.5 Organogenesis Recent Developments/Updates
6.10 Flower Orthopedics
6.10.1 Flower Orthopedics Company Information
6.10.2 Flower Orthopedics Description and Business Overview
6.10.3 Flower Orthopedics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Flower Orthopedics Artificial Dermis Product Portfolio
6.10.5 Flower Orthopedics Recent Developments/Updates
6.11 Promethean
6.11.1 Promethean Company Information
6.11.2 Promethean Description and Business Overview
6.11.3 Promethean Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Promethean Artificial Dermis Product Portfolio
6.11.5 Promethean Recent Developments/Updates
6.12 Wright Medical Group
6.12.1 Wright Medical Group Company Information
6.12.2 Wright Medical Group Description and Business Overview
6.12.3 Wright Medical Group Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Wright Medical Group Artificial Dermis Product Portfolio
6.12.5 Wright Medical Group Recent Developments/Updates
6.13 Aziyo Biologics
6.13.1 Aziyo Biologics Company Information
6.13.2 Aziyo Biologics Description and Business Overview
6.13.3 Aziyo Biologics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aziyo Biologics Artificial Dermis Product Portfolio
6.13.5 Aziyo Biologics Recent Developments/Updates
6.14 RTI Surgical
6.14.1 RTI Surgical Company Information
6.14.2 RTI Surgical Description and Business Overview
6.14.3 RTI Surgical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.14.4 RTI Surgical Artificial Dermis Product Portfolio
6.14.5 RTI Surgical Recent Developments/Updates
6.15 MiMedx Group
6.15.1 MiMedx Group Company Information
6.15.2 MiMedx Group Description and Business Overview
6.15.3 MiMedx Group Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.15.4 MiMedx Group Artificial Dermis Product Portfolio
6.15.5 MiMedx Group Recent Developments/Updates
6.16 Tides Medical
6.16.1 Tides Medical Company Information
6.16.2 Tides Medical Description and Business Overview
6.16.3 Tides Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Tides Medical Artificial Dermis Product Portfolio
6.16.5 Tides Medical Recent Developments/Updates
6.17 Ventris Medical
6.17.1 Ventris Medical Company Information
6.17.2 Ventris Medical Description and Business Overview
6.17.3 Ventris Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Ventris Medical Artificial Dermis Product Portfolio
6.17.5 Ventris Medical Recent Developments/Updates
6.18 Vivex Biomedical
6.18.1 Vivex Biomedical Company Information
6.18.2 Vivex Biomedical Description and Business Overview
6.18.3 Vivex Biomedical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Vivex Biomedical Artificial Dermis Product Portfolio
6.18.5 Vivex Biomedical Recent Developments/Updates
6.19 Aedicell
6.19.1 Aedicell Company Information
6.19.2 Aedicell Description and Business Overview
6.19.3 Aedicell Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Aedicell Artificial Dermis Product Portfolio
6.19.5 Aedicell Recent Developments/Updates
6.20 Amniox Medical
6.20.1 Amniox Medical Company Information
6.20.2 Amniox Medical Description and Business Overview
6.20.3 Amniox Medical Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Amniox Medical Artificial Dermis Product Portfolio
6.20.5 Amniox Medical Recent Developments/Updates
6.21 StimLabs
6.21.1 StimLabs Company Information
6.21.2 StimLabs Description and Business Overview
6.21.3 StimLabs Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.21.4 StimLabs Artificial Dermis Product Portfolio
6.21.5 StimLabs Recent Developments/Updates
6.22 Skye Biologics
6.22.1 Skye Biologics Company Information
6.22.2 Skye Biologics Description and Business Overview
6.22.3 Skye Biologics Artificial Dermis Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Skye Biologics Artificial Dermis Product Portfolio
6.22.5 Skye Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Dermis Industry Chain Analysis
7.2 Artificial Dermis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Dermis Production Mode & Process Analysis
7.4 Artificial Dermis Sales and Marketing
7.4.1 Artificial Dermis Sales Channels
7.4.2 Artificial Dermis Distributors
7.5 Artificial Dermis Customer Analysis
8 Artificial Dermis Market Dynamics
8.1 Artificial Dermis Industry Trends
8.2 Artificial Dermis Market Drivers
8.3 Artificial Dermis Market Challenges
8.4 Artificial Dermis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Artificial Dermis was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 160
USD 3950.00
(Single User License)
The global Artificial Dermis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 146
USD 2900.00
(Single User License)
The global Artificial Dermis market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 113
USD 4250.00
(Single User License)
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 196
USD 4900.00
(Single User License)
The global market for Artificial Dermis was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 160
USD 3950.00
(Single User License)
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-12
Pages: 127
USD 4900.00
(Single User License)
The global Artificial Dermis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 109
USD 2900.00
(Single User License)
The global market for Artificial Dermis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-07
Pages: 154
USD 3950.00
(Single User License)
The global market for Artificial Dermis was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 160
The global Artificial Dermis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 146
The global Artificial Dermis market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 113
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 196
The global market for Artificial Dermis was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 160
The global Artificial Dermis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-12
Pages: 127
The global Artificial Dermis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 109
The global market for Artificial Dermis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-07
Pages: 154
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now